HIV death rate in SA men much higher than in women

HIV death rate in SA men much higher than in women

While men account for only a third of South Africa’s roughly 200 000 new HIV infections in the year ending mid-2019, they account for more than half of the approximately 74 000 HIV-related deaths in the same period. This is according to new estimates released on Tuesday from the Thembisa mathematical model of HIV in South Africa.

Read More

HIV prevention injection hailed as a “major breakthrough” for women

HIV prevention injection hailed as a “major breakthrough” for women

Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers have been hailed as being a “game-changer” to turn “the tide on HIV” as it effectively reduces HIV acquisition and provides women more choices in how to protect themselves. Amy Green reports.

Read More

TB treatment time cut by a third

TB treatment time cut by a third

A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.

Read More

The promise of HIV prevention injections and how they work

The promise of HIV prevention injections and how they work

Antiretroviral (ARV) injections that may protect women from becoming HIV-positive, if proved to be safe and effective, will be a major step forward in the fight against the HIV pandemic. Siyabonga Kamnqa reports.

Read More

Interview: Dr Thembisile Xulu – the new CEO of SANAC

Interview: Dr Thembisile Xulu – the new CEO of SANAC

Dr Thembisile Xulu was recently appointed as the new CEO of the South African National AIDS Council (SANAC). On her second day in office, Bienne Huisman spoke to Xulu about her new role, her love of medicine, and growing up in a family of strong women.

Read More

1.3m switched to new ARV, but weight gain is a concern

1.3m switched to new ARV, but weight gain is a concern

Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.

Read More

Libyan embassy allegedly pressuring SA workers to test for HIV

Libyan embassy allegedly pressuring SA workers to test for HIV

The Department of International Relations and Cooperation is investigating allegations that South Africans working at the Libyan embassy in Pretoria were pressured to test and reveal their HIV status after asking to be tested for COVID-19.

Read More

Vaginal ring ushers in new era in HIV prevention

Vaginal ring ushers in new era in HIV prevention

A recent announcement about a vaginal ring to prevent HIV has AIDS activists and women’s sexual and reproductive health advocates excited. But where would this ring fit in South Africa’s HIV prevention programme? Amy Green investigates.

Read More

COVID-19: Sex workers say they struggle to access contraception, abortion and other services

COVID-19: Sex workers say they struggle to access contraception, abortion and other services

The COVID-19 pandemic and South Africa’s national lockdown has exacerbated existing challenges the LGBTQI+ community and sex workers experience in accessing sexual and reproductive healthcare services. Tiyese Jeranji reports.

Read More

Being young and living with HIV in the time of COVID-19

Being young and living with HIV in the time of COVID-19

Stigma and discrimination makes accessing healthcare services hard for many young people living with HIV. Has it become even harder during the COVID-19 pandemic? Nomfundo Xolo spoke to young people and activists in KwaZulu-Natal.

Read More